Novo Nordisk Partners with Vivani Medical to Develop GLP-1 Implant for Long-Term Weight Loss Maintenance
Vivani Medical is developing a GLP-1 implant aimed at helping patients maintain weight loss long-term, addressing challenges associated with current treatments. This innovation could significantly impact the obesity treatment market, which is projected to exceed $100 billion by the early 2030s.